The Influence of Proton Pump Inhibitors (PPI's) on Blood Levels of 25-Hydroxyvitamin D.
Withdrawn before enrolling
Conditions studied: Vitamin D
In brief
The purpose of this study is to demonstrate if Proton Pump Inhibitors (PPI's) decrease blood levels of 25-Hydroxyvitamin D (25-OH Vitamin D).
Key facts
- Study ID
- NCT01302704
- Run by
- Mike O'Callaghan Military Hospital
- People needed
- 0
- Starts
- 2012-04-01
- Expected to finish
- 2013-11-01
- Last updated by the study team
- 2013-11-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Tricare Insurance Beneficiary (military insurance) receiving care at Nellis AFB
- Male and Female (DoD beneficiaries) at least 18 years of age and have lived in the Las Vegas area for at least 3 months.
You may not qualify if…
- Subjects less than 18 years of age.
- Subjects that have known malabsorption conditions.
- 25-OH Vitamin D less than 10
- Pregnancy
- Non English speaking
- Taking any prescription medication or over the counter antacids
- Vitamin d supplements (excluding multivitamin supplements due to relatively low dose of vitamin D)
- Any medical condition that requires regular monitoring by health care provider
Where it is running
- Mike O'Callaghan Federal Hospital — Nellis Air Force Base, Nevada, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.